DaVita Inc. (DVA)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for DVA is $232.66, 24.2% above the last close of $187.31 on Oct 16, 2026; targets range from $185.39 to $273.91. Rating consensus: Hold.
Snapshot
- P/E16.5x
- P/E vs sector-41.5%
- P/E vs own+7.5%
- Target upside+24.2%
- ConsensusHold
- Market cap$11.95B
- FCF yield+13.5%
- Insiders-$36.51M
- Earnings in12d
- News0.00
Why it moved
DaVita Inc. (DVA) fell 1.0% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move came from the market as a whole.
0 stories on the day (30-day average 0.4).
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $187.31 · +49.5% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendbullish
- Sector▲ +16.0%
- MAs20▲ 50▲ 100▼ 200▲
- Above MAs3 of 4 above
- MA20×50↑ in ~2d
- RSI58
- Support-6.2%
- Resistance+2.2%
- Off 52w high-22.3%
- Off ATH-22.3%
- 52w range$187.31
- Bollingerupper half
- MACD1.48
- ATR+2.5%
- Volume0.9x
Analyst price targets
6 firms with a target in the last 12 months · last close $187.31 · as of Oct 16, 2026
Strong buy 0 · Buy 3 · Hold 4 · Sell 0 · Strong sell 1
Revenue and free cash flow
Q2 FY2026: Revenue +5.2% year over year, free cash flow 9.0% of revenue, operating margin 16.1%.
| Q2 FY2026 | Jun 30, 2026 | $3.55B | 4.02 | $320M | 32.7% | 16.1% | 7.5% |
| Q1 FY2026 | Mar 31, 2026 | $3.42B | 2.87 | $219M | 31.4% | 14.1% | 5.8% |
| Q4 FY2025 | Dec 31, 2025 | $3.62B | 2.45 | $395M | 28.3% | 15.2% | 6.5% |
| Q3 FY2025 | Sep 30, 2025 | $3.42B | 2.04 | $675M | 31.8% | 14.8% | 4.4% |
| Q2 FY2025 | Jun 30, 2025 | $3.38B | 2.58 | $203M | 33.1% | 15.9% | 5.9% |
| Q1 FY2025 | Mar 31, 2025 | $3.22B | 2.00 | $36.75M | 30.5% | 13.6% | 5.1% |
| Q4 FY2024 | Dec 31, 2024 | $3.29B | 3.09 | $377M | 32.5% | 17.2% | 7.9% |
| Q3 FY2024 | Sep 30, 2024 | $3.26B | 2.50 | $671M | 34.1% | 16.4% | 6.6% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $458.84 | -2.1% | -15.4% | +2.1% | 15.4 | $99.34B | |
| 2 |  | $300.15 | -2.0% | -3.4% | +3.1% | — | $14.46B | |
| 3 |  | $25.28 | -1.9% | -10.8% | -14.8% | — | $13.07B | |
| 4 | | $187.31 | -1.0% | -22.3% | +24.2% | 16.5 | $11.95B | |
| 5 |  | $72.57 | +0.1% | -0.1% | -7.0% | 62.6 | $11.38B | |
| 6 |  | $57.94 | +0.9% | -31.3% | +0.9% | 19.8 | $11.02B | |
| 7 |  | $185.10 | -1.2% | -23.9% | +11.1% | 7.6 | $10.91B | |
| 8 |  | $147.31 | -1.4% | -25.4% | +35.1% | 25.6 | $10.46B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.